On the other hand, HMGCR inhibitor showed a significant reduction in the risk of menorrhagia in female patients (IVW: OR [95%CI] = 0.8639 [0.7229, 1.0050], p=4.21× 10−2) (Figure 2). This evidence concerns the gene HMGCR and Menorrhagia.